Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease

Journal of Rheumatology

Volumn 26, Issue 2, 1999, Pages 373-378

  Fautrel, Bruno ^a   Borget, Cécile ^b   Rozenberg, Sylvie ^b   Meyer, Olivier ^b   Le Loët, Xavier ^b   Masson, Charles ^b   Koeger, Anne Claude ^b   Kahn, Marcel Francis ^b   Bourgeois, Pierre ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

Adult Still's disease; Corticosteroid; Methotrexate; Prednisone; Treatment

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHOTREXATE; PENICILLAMINE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MALE; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; BLOOD SEDIMENTATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; STILL'S DISEASE, ADULT-ONSET; TIME FACTORS; TREATMENT OUTCOME;

EID: 0032954456     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bywaters EGL. Still's disease in the adult. Ann Rheum Dis 1971;30:121-33.
2. Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.
3. Reginato AJ, Schumacher HR, Baker DG, O'Connor CR, Ferreiros J. Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum 1987;17:39-57.
4. Ohta A, Yamaguchi M, Tsunematsu T, et al. Adult Still's disease: a multicenter survey of Japanese patients. J Rheumatol 1990; 17:1058-63.
5. Pouchot J, Sampalis JS, Beaudet F, et al. Adult Still's disease: manifestations, disease course and outcome in 62 patients. Medicine (Baltimore) 1991;70:118-36.
6. Masson C, Le Loët X, Lioté F, et al. Adult Still's disease. I. Manifestations and complications in 65 cases in France. Rev Rhum [Engl Ed] 1995;62:748-57.
7. Ohta A, Yamaguchi M, Kaneoka H, Nagayoshi T, Hiida M. Adult Still's disease: review of 228 cases from literature. J Rheumatol 1987;14:1139-46.
8. Wouters JMGW, van de Putte LBA. Adult-onset Still's disease: clinical and laboratory features, treatment and progress of 45 cases. Q J Med 1986;61:1055-65.
9. Cush JJ, Medsger TA, Christy WC, Herbert DC, Cooperstein LA. Adult-onset Still's disease. Clinical course and outcome. Arthritis Rheum 1987;30:186-94.
10. Masson C, Le Loët X, Lioté F, et al. Adult Still's disease. II. Management, outcome and prognostic factors. Rev Rhum [Engl Ed] 1995;62:758-65.
11. Khraishi M, Fam AG, Treatment of fulminant adult Still's disease with intravenous pulse methylprednisolone therapy. J Rheumatol 1991;18:1088-90.
12. Bisagni-Faure A, Job-Deslandre C, Menkes CJ. Intravenous methylprednisolone pulse therapy in Still's disease. J Rheumatol 1992;19:1487-8.
13. Kraus A, Alarcon-Segovia D, Fever in adult-onset Still's disease. Response to methotrexate. J Rheumatol 1991;18:918-20.
14. Aydintug AO, D'Cruz D, Cervera R, Khamashta MA, Hughes GRV. Low dose methotrexate treatment in adult Still's disease. J Rheumatol 1992;19:431-5.
15. Fujii T, Akizuki M, Kameda H, et al. Methotrexate treatment in patients with adult-onset Still's disease. Retrospective study of 13 Japanese cases. Ann Rheum Dis 1997;56:144-8.
16. Del Paine DW, Leek JC. Still's arthritis in adults: disease or syndrome? J Rheumatol 1983;10:758-62.
17. Larson EB. Adult Still's disease. Evolution of a clinical syndrome and diagnosis, treatment and follow-up of 17 patients. Medicine (Baltimore) 1984;63:82-91.
18. Bourgeois P, Palazzo E, Belmatoug N, Kahn MF. Low dose methotrexate in adult Still's disease: second line treatment or steroid sparing? [abstract]. Arthritis Rheum 1989; Suppl 32:B63.
19. Hu SK, Mitcho YL, Oronsky AL, Kerwar SS. Studies of the effect of methotrexate on macrophage functions. J Rheumatol 1988;15:206-9.
20. Segal R, Mozes E, Yaron M, Tartakovsky B. The effects of methotrexate on the production and activity of interleukin-1. Arthritis Rheum 1989;32:370-7.
21. Meyer FA, Yaron I, Mashiah V, Yaron M. Methotrexate inhibits proliferation but not interleukin 1 stimulated secretory activities of cultured human synovial fibroblasts. J Rheumatol 1993;20:238-42.
22. Cronstein BN. Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum 1996;39:1951-60.
23. Rogers JT, Bridges KR, Durmowicz GP, Glass J, Auron PE, Munro HN. Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1. J Biol Chem 1990;265: 14572-8.
24. Cronstein BN, Naime D, Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminished leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 1993;92:2675-82.
25. Berthelot JM, Maugars Y, Hamidou M, et al. Pancytopenia and severe cytopenia induced by low dose methotrexate. Eight case-reports and a review of 100 cases from the literature (with 24 deaths). Rev Rhum [Engl Ed] 1995;62:477-86.
26. Michel M, Hayem G, Rat AC, et al. Complications infectieuses fatales chez deux patients atteints de maladie de Still de l'adulte. Rev Med Interne 1996;17:407-9.
27. Fries JF, Singh G, Lenert L, Furst DE. Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis. Arthritis Rheum 1990;33:1611-9.
28. Stewart CF, Fleming RA, Germain BF, Seleznick MJ, Evans WE. Aspirin alters methotrexate disposition in rheumatoid arthritis patients. Arthritis Rheum 1991;34:1514-20.